What we do
Developing and implementing cutting-edge proteomics and metabolomics technology for analyzing disease-associated molecular mechanisms and fingerprints within all research focus areas of the LUMC, to promote innovation within biomedical research and public health.
Research
The CPM develop and implement key technology for proteomics, glycomics and metabolomics research at the LUMC. This includes mass spectrometry (MS) hyphenated to liquid chromatography, capillary electrophoresis, and gas chromatography, as well as nuclear magnetic resonance (NMR).
News
-
-
Thesis defense Daniel A. Demus
-
EU Mission on Cancer Grant for Spatial Omics in Lung Cancer Research
-
Sigourney Karijodikoro received the flash presentation award at the ROLDUC 2024 meeting
-
Christoph Gstöttner received the young scientist award
-
Thesis defense Wei Wang